FAFTFSNP
RPRX icon

Fjarde AP-fonden (The Fourth Swedish National Pensionfund)’s Royalty Pharma RPRX Stock Holding History

Fjarde AP-fonden (The Fourth Swedish National Pensionfund)’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		$1.79M Buy
+68,050
New +$1.89M 0.02% 474

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Fjarde AP-fonden (The Fourth Swedish National Pensionfund)'s RPRX Position: Q2 2024 in Review

Fjarde AP-fonden (The Fourth Swedish National Pensionfund) opened a new position in Royalty Pharma (RPRX) in Q2 2024: 68,050 shares worth $1.79M. The stake represents 0.02% of the portfolio and ranks #474 among its holdings.

378 funds tracked by Wall St. Rank hold RPRX as of Q2 2024.

  • Fjarde AP-fonden (The Fourth Swedish National Pensionfund) held 68,050 shares of Royalty Pharma worth $1.79M as of Q2 2024.
  • Royalty Pharma was a new Fjarde AP-fonden (The Fourth Swedish National Pensionfund) position in Q2 2024.
  • Royalty Pharma made up 0.02% of Fjarde AP-fonden (The Fourth Swedish National Pensionfund)'s portfolio in Q2 2024, its #474 holding.
  • 378 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2024.

Based on Fjarde AP-fonden (The Fourth Swedish National Pensionfund)'s 13F filing for Q2 2024, filed 2 Aug 2024.